MSH2 and colorectal carcinoma: Traditionally, CRC is thought to emerge through the adenoma-carcinoma pathway, but growing evidence shows that it is not applicable to all LS cases: regular and frequent colonoscopy surveillance and removal of colorectal adenomas have not significantly decreased the lifetime risk of CRC in MLH1 and MSH2 carriers [3].